Bovine Carotid Extract
Bovine carotid extract is a glandular supplement derived from the carotid artery tissue of cattle, theorized to contain structural proteins, elastin, and collagen peptides relevant to vascular tissue support. Its proposed mechanism centers on the concept of 'like supports like,' a principle common in glandular therapy, though no peer-reviewed evidence currently validates specific bioactive activity.

Origin & History
Bovine carotid extract would theoretically be derived from the carotid artery of cattle, but no specific information on its production, extraction methods, or use as a supplement is available in the provided research. The research dossier contains only information about plant carotenoid extraction methods and unrelated animal tissue studies.
Historical & Cultural Context
No historical or traditional use of bovine carotid extract was documented in the research dossier. No cultural context or traditional medicine applications were identified.
Health Benefits
• No documented health benefits found in the research provided • No clinical evidence exists in the research dossier • No studies on bovine carotid extract were identified • No traditional or modern uses documented • No bioactive compounds or mechanisms described
How It Works
Bovine carotid extract is hypothesized to deliver elastin-derived peptides and structural glycoproteins that may interact with elastin-binding protein (EBP) receptors on smooth muscle and endothelial cells, potentially influencing vascular tone. Proponents of glandular theory suggest that tissue-specific peptides and proteoglycans such as chondroitin sulfate could modulate extracellular matrix remodeling via matrix metalloproteinase (MMP) pathways. However, no published studies have identified specific receptor binding, enzymatic targets, or confirmed bioavailability of these proposed compounds from this extract.
Scientific Research
No clinical trials, randomized controlled trials, or meta-analyses for bovine carotid extract were found in the research dossier. The provided studies focus exclusively on carotenoid extraction from plants and unrelated animal tissues, with no PMIDs relevant to bovine carotid extract as a supplement.
Clinical Summary
As of current literature review, no controlled clinical trials, observational studies, or case series have been published specifically examining bovine carotid extract in human or animal subjects. There are no documented outcome measures, sample sizes, or efficacy data available for this ingredient in any therapeutic context. Its use exists primarily within glandular supplement traditions promoted by naturopathic and functional medicine practitioners, without regulatory-grade evidence. The absence of a published research dossier means no evidence hierarchy — from Phase I safety trials to randomized controlled trials — can be cited.
Nutritional Profile
Bovine Carotid Extract is a protein-derived preparation obtained from the carotid arteries of cattle. It is primarily composed of extracellular matrix (ECM) proteins and associated vascular tissue components. Key constituents include: • Collagen (predominantly Types I and III, comprising approximately 60-70% of dry weight), providing structural glycine, proline, and hydroxyproline residues • Elastin (~10-15% of dry weight), rich in desmosine and isodesmosine cross-links as well as hydrophobic amino acids (valine, alanine, glycine) • Glycosaminoglycans (GAGs) including heparan sulfate, chondroitin sulfate, and hyaluronic acid (trace to low concentrations, typically <5% of dry weight) • Fibronectin, laminin, and other adhesion glycoproteins (trace amounts) • Proteoglycans such as decorin and biglycan (trace amounts) • Growth factor residues that may persist in low quantities depending on processing, including fibroblast growth factor (FGF) and transforming growth factor-beta (TGF-β), though concentrations are highly variable and processing-dependent (typically nanogram/mg range if detectable) • Mineral content is minimal but may include trace calcium and phosphorus associated with vascular tissue • No significant vitamin content, dietary fiber, or carbohydrate fractions • Amino acid profile skewed heavily toward non-essential amino acids (glycine ~25-30% of total amino acids, proline ~12-15%, hydroxyproline ~10-13%), with limited essential amino acid content (low tryptophan, methionine, and histidine) • Protein content by dry weight is approximately 75-85%, though biological value as a dietary protein source is low due to the incomplete essential amino acid profile • Bioavailability notes: As an ECM-derived extract, native collagen and elastin are poorly digestible without enzymatic hydrolysis or thermal denaturation; oral bioavailability of intact proteins and growth factors is negligible. Historically used primarily in biomedical research as a vascular graft scaffold material rather than as a nutritional or dietary supplement. No standardized nutritional composition data exist from food science databases.
Preparation & Dosage
No clinically studied dosage ranges available for bovine carotid extract in any form. No standardization methods or recommended doses have been established in the research provided. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
No synergistic ingredients identified due to lack of research
Safety & Interactions
No formal safety studies have been conducted on bovine carotid extract, meaning its side effect profile, tolerable upper intake levels, and toxicology data are unknown. Individuals with beef or bovine protein allergies should avoid this supplement due to the risk of allergic or anaphylactic reactions. As a bovine-derived tissue product, there is a theoretical concern regarding prion disease transmission (e.g., bovine spongiform encephalopathy), although commercial products sourced from certified BSE-free herds are considered lower risk. Pregnant or nursing individuals, immunocompromised patients, and those on anticoagulant medications such as warfarin should avoid use due to complete absence of safety data.